Brian E Levy

US Patent:

8396780, Mar 12, 2013

Filed:

Jun 21, 2000

Appl. No.:

09/599051

Inventors:

Michael J. Witz - Los Angeles CA, US
Brian A. Levy - Los Angeles CA, US
Brian N. Sawyer - Santa Monica CA, US
Dan Lin - Culver City CA, US
Gordon K. Gustafson - Encino CA, US

Assignee:

eBay, Inc. - San Jose CA

International Classification:

G06Q 40/00

US Classification:

705 37

Abstract:

A method of creating a financial product. A virtual community is established. Members of the community submit preferences to a server. The preferences are aggregated and manipulated to identify characteristics of the preferences. From the population of preferences submitted, a small subset is identified to be part of the financial product.

US Patent:

8459793, Jun 11, 2013

Filed:

Sep 13, 2012

Appl. No.:

13/615111

Inventors:

Cary J. Reich - Los Gatos CA, US
Yair Alster - Palo Alto CA, US
K. Angela Macfarlane - Woodside CA, US
Doug Rimer - Los Altos Hills CA, US
Douglas Sutton - Pacifica CA, US
Dean Carson - Mountain View CA, US
Enrique Barragan - Monterrey, MX
Matt Clarke - Menlo Park CA, US
Ashley Tuan - Menlo Park CA, US
Brian Levy - New York NY, US

Assignee:

NexisVision, Inc. - Menlo Park CA

International Classification:

A61B 3/14
A61B 3/00

US Classification:

351207, 351246

Abstract:

A conformable covering comprises an outer portion with rigidity to resist movement on the cornea and an inner portion to contact the cornea and provide an environment for epithelial regeneration. The inner portion of the covering can be configured in many ways so as to conform at least partially to an ablated stromal surface so as to correct vision. The conformable inner portion may have at least some rigidity so as to smooth the epithelium such that the epithelium regenerates rapidly and is guided with the covering so as to form a smooth layer for vision. The inner portion may comprise an amount of rigidity within a range from about 1×10-4 Pa*m3 to about 5×10-4 Pa*m3 so as to deflect and conform at least partially to the ablated cornea and smooth an inner portion of the ablation with an amount of pressure when deflected.

US Patent:

8591025, Nov 26, 2013

Filed:

Dec 14, 2012

Appl. No.:

13/715917

Inventors:

Cary J. Reich - Los Gatos CA, US
Yair Alster - Palo Alto CA, US
Matt Clarke - Menlo Park CA, US
Brian Levy - New York NY, US

Assignee:

NexisVision, Inc. - Menlo Park CA

International Classification:

G02C 7/04

US Classification:

35115904, 606 5, 623 511, 623 513

Abstract:

A method for providing faster visual and functional recovery of patients following refractive surgery such as laser assisted in situ keratomileusis (LASIK) is disclosed. The method comprises providing a covering to the eye of a patient comprising an inner portion having an inner rigidity and at least one inner radius of curvature; and an outer portion having an outer rigidity and at least one outer radius of curvature; wherein the inner rigidity is greater than the outer rigidity.

US Patent:

20060257391, Nov 16, 2006

Filed:

May 11, 2005

Appl. No.:

11/126625

Inventors:

Stephen Bartels - New York NY, US
Gregory McIntire - Rochester NY, US
Timothy Comstock - Rochester NY, US
Brian Levy - Rochester NY, US

International Classification:

A61K 38/48

US Classification:

424094640

Abstract:

A non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy to the proliferative form of diabetic retinopathy comprising intravitreally administering to a patient suffering from non-proliferative diabetic retinopathy an effective amount of serine proteinase enzyme sufficient to create, without surgery, a posterior vitreal detachment to prevent or reduce the progression of proliferative diabetic retinopathy in said patient. Also disclosed is a non-surgical method of treating ocular conditions such as retinal ischemia, retinal inflammation, retinal edema tractional retinal detachment, tractional retinopathy, vitreous hemorrhage and tractional maculopathy by intravitreally administering to a patient suffering from one or more of these conditions with an effective amount of a serine proteinase enzyme to reduce or treat that particular ocular condition. Plasmin, microplasmin and miniplasmin are preferred serine proteinase enzymes and plasmin is the most preferred.

US Patent:

20080215988, Sep 4, 2008

Filed:

Dec 28, 2007

Appl. No.:

11/966278

Inventors:

Michael J. Witz - Los Angeles CA, US
Brian A. Levy - Los Angeles CA, US
Brian N. Sawyer - Santa Monica CA, US
Dan Lin - Culver City CA, US
Gordon K. Gustafson - Encino CA, US

International Classification:

G06F 3/00

US Classification:

715738

Abstract:

A method of creating a financial product. A virtual community is established. Members of the community submit preferences to a server. The preferences are aggregated and manipulated to identify characteristics of the preferences. From the population of preferences submitted, a small subset is identified to be part of the financial product.

US Patent:

20100305514, Dec 2, 2010

Filed:

Jan 9, 2009

Appl. No.:

12/812171

Inventors:

Michael J. Valenti - Rochester NY, US
Stephen P. Bartels - Pittsford NY, US
Stephen R. Davio - Fairport NY, US
Francesco P. Rotoli - Rochester NY, US
Brian Levy - New York NY, US

Assignee:

BAUSCH & LOMB INCORPORATED - Rochester NY

International Classification:

A61M 5/32

US Classification:

604239

Abstract:

An ophthalmic injection system having coaxial cannulae includes a plurality of syringe bodies and a plurality of cannulae, wherein a first non-flexible cannula is configured to accommodate and guide a second cannula that moves inside the first cannula and penetrates into the internal cavity of an eye globe. The first cannula is long enough to penetrate one or more outer layers of the eye globe. A syringe body is connected to the second cannula for accommodation and infusion of a pharmaceutical composition. A plunger is inserted into an annular space of the second syringe body at its distal end for injecting the pharmaceutical composition to the surgical site.

US Patent:

20110020453, Jan 27, 2011

Filed:

Feb 8, 2010

Appl. No.:

12/702064

Inventors:

Steven Blum - New York NY, US
Barrett Katz - New York NY, US
Christopher Wilfong - New York NY, US
Brian Levy - New York NY, US

International Classification:

A61K 9/14
A61K 31/352
A61P 27/06

US Classification:

424489, 514456, 977773, 977788, 977915

Abstract:

Disclosed herein are pharmaceutical formulations comprising particles of formula 1:wherein R, R, R, R, R, R, n and * are each defined in specification. Also disclosed are methods of decreasing intraocular pressure comprising topically applying a benzopyranyl guanidine derivative of formula 1 to an eye.

US Patent:

20110070310, Mar 24, 2011

Filed:

Dec 14, 2010

Appl. No.:

12/967618

Inventors:

Steven Blum - New York NY, US
Barrett Katz - New York NY, US
Christopher Wilfong - New York NY, US
Brian Levy - New York NY, US

Assignee:

MESH THERAPEUTICS, LLC - New York NY

International Classification:

A61K 31/352
A61K 9/14
A61P 27/06

US Classification:

424489, 514456

Abstract:

A topical ophthalmic pharmaceutical formulation may include particles of the compound (2S,3S,4R)—N″-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N′-benzylguanidine suspended in a solution comprising monobasic sodium phosphate monohydrate, disodium phosphate heptahydrate, edetate disodium, benzalkonium chloride, sodium chloride, polysorbate 80, and water. A method of treating glaucoma may include topically applying to the eye of a patient in need thereof a therapeutically effective amount of this formulation.